Delivery Order SPE2DB24D2101-SPE2DB25FKLHX
Award Date
6/11/25
Potential Completion Date
7/3/25
Potential Value
$25K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of KRAZATI 200 MG TABLET 180S, a medical product, with a ceiling value of $12,629.53 and a period of performance ending on April 2, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp is the prime contractor, and this...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,207.62 firm fixed-price delivery order is for the supply of KRAZATI 200 MG TABLET 180S, with an ultimate completion date of December 5, 2024. The contract is not designated with a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,207.62 fixed-price delivery order is for the supply of KRAZATI 200 MG TABLET 180S, with a completion date of November 13, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award, valued at $12,629.53, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the delivery of 4566946899 ! KRAZATI 200 MG TABLET 180S, which are pharmaceutical products. The contract has an ultimate completion date of February 6, 2025 and is a Firm Fixed Price Delivery Order. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $1,957.44 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of KATERZIA 1 MG/ML SUSPENSION 150ML, a pharmaceutical product, and has a completion date of June 13, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle...
This is a $1,059.76 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract is for the supply of KATERZIA 1 MG/ML SUSPENSION 150ML, a pharmaceutical product. The contract has an ultimate completion date of July 7, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of a pharmaceutical product, KETORL 60MG/2ML VI 25S, with a ceiling value of $1,693.55. The contract has a firm fixed price and an ultimate completion date of September 3, 2024. Amerisourcebergen is a for-profit organization and a significant supplier of medical commodities to various federal...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,090.00 contract is for the delivery of various pharmaceutical products and medical supplies to support federal agencies, particularly military and veteran healthcare programs. The contract is not set aside and allows for multiple delivery orders across different therapeutic categories,...
This federal contract award, valued at $13,920.91, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ORSERDU 345 MG TABLET 30S, a prescription medication, with a performance period ending on May 28, 2025. The contract is a Delivery Order under a broader Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999.00. This...
This is a $65,623.52 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of pharmaceutical products and medical supplies, including medications across various therapeutic areas such as diabetes, neurology, pain management, and antibiotics. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) that...